Prestige Consumer Healthcare Inc.
- Last sale
- Nov 12, 2026 · +2.56%
- Market cap
- $2.15B
- 47.4M shares
- Filings
- 1,021
Q2 2027−4.3% FY26 yoy
Q2 2027−11.3% FY26 yoy
Q2 2027−8.1% FY26 yoy
Q2 2027derived+1.3% FY26 yoy
Q2 2027−8.9% FY26 yoy
Q2 2027−34.8% FY26 yoy
- $2.15B
- 13.8×
- 1.8×
- 1.1×
- 9.97%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | $1,088,705,000 | reported | |
| FY 2025 | 2025-03-31 | $1,137,762,000 | reported | |
| FY 2024 | 2024-03-31 | $1,125,357,000 | reported | |
| FY 2023 | 2023-03-31 | $1,127,725,000 | reported | |
| FY 2022 | 2022-03-31 | $1,086,812,000 | reported | |
| FY 2021 | 2021-03-31 | $943,365,000 | reported | |
| FY 2020 | 2020-03-31 | $963,010,000 | reported | |
| FY 2019 | 2019-03-31 | $975,777,000 | reported | |
| FY 2018 | 2018-03-31 | $1,041,179,000 | reported | |
| FY 2017 | 2017-03-31 | $882,060,000 | reported | |
| FY 2016 | 2016-03-31 | $806,247,000 | reported | |
| FY 2015 | 2015-03-31 | $713,457,000 revised | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | — | $156.28M | $156.28M | — | 47.37M sh | −4.1% | 63.4% |
| FY2025 | — | $51.51M | $51.51M | — | 49.41M sh | −1.0% | 21.2% |
| FY2024 | — | $25.00M | $25.00M | — | 49.92M sh | +0.4% | 10.4% |
| FY2023 | — | $50.00M | $50.00M | — | 49.69M sh | −1.2% | 22.5% |
| FY2022 | — | $0.00 | $0.00 | — | 50.28M sh | +0.7% | 0.0% |
Segments
LineFY2026ShareChange
North American OTC Healthcare$913.58M84%−4.8%
International OTC Healthcare$175.13M16%−1.5%
Household Cleaning———
Total$1.09B
Pharmaceutical preparations
Prestige Consumer Healthcare Inc. is the 33rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SUPNSupernus, Inc.$1.2B4.3%16.9%$3.4BNSRXNasus Pharma Ltd$1.2B—0.5%$26.6M
PBHPrestige Consumer Healthcare Inc. (this company)$1.1B4.3%17.5%$2.1B
ACADAcadia Pharmaceuticals Inc$1.1B11.9%36.5%$3.7BLEGNLegend Biotech Corp$1.0B64.0%28.8%$3.4BMDGLMadrigal Pharmaceuticals, Inc.$958.4M432.1%30.1%$9.9BIONSIonis Pharmaceuticals Inc$943.7M33.8%40.4%$4.5BANIPANI Pharmaceuticals Inc$883.4M43.8%8.9%$1.6BHRMYHarmony Biosciences Holdings, Inc.$868.5M21.5%18.3%$2.0BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR